AAAAAA

   
Results: 1-8 |
Results: 8
Bone scan had no role in the staging of 765 consecutive operable T1-2N0-1 breast cancer patients without skeletal symptoms
Authors: Curigliano, G Ferretti, G Colleoni, M Marrocco, E Peruzzotti, G De Cicco, C Paganelli, G Goldhirsch, A
Citation: G. Curigliano et al., Bone scan had no role in the staging of 765 consecutive operable T1-2N0-1 breast cancer patients without skeletal symptoms, ANN ONCOL, 12(5), 2001, pp. 724-725
Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: A phase II study
Authors: Nole, F Munzone, E Mandala, M Catania, C Orlando, L Zampino, MG Minchella, I Colleoni, M Peruzzotti, G Marrocco, E Goldhirsch, A
Citation: F. Nole et al., Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: A phase II study, ANN ONCOL, 12(1), 2001, pp. 95-100
Response to primary chemotherapy in breast cancer patients with tumors notexpressing estrogen and progesterone receptors
Authors: Colleoni, M Minchella, I Mazzarol, G Nole, F Peruzzotti, G Rocca, A Viale, G Orlando, L Ferretti, G Curigliano, G Veronesi, P Intra, M Goldhirsch, A
Citation: M. Colleoni et al., Response to primary chemotherapy in breast cancer patients with tumors notexpressing estrogen and progesterone receptors, ANN ONCOL, 11(8), 2000, pp. 1057-1059
Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): Is prophylaxis required?
Authors: Orlando, L Colleoni, M Nole, F Biffi, R Rocca, A Curigliano, G Ferretti, G Peruzzotti, G de Braud, F Masci, G Goldhirsch, A
Citation: L. Orlando et al., Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): Is prophylaxis required?, ANN ONCOL, 11(1), 2000, pp. 117-118
Depression and degree of acceptance of adjuvant cytotoxic drugs
Authors: Colleoni, M Mandala, M Peruzzotti, G Robertson, C Bredart, A Goldhirsch, A
Citation: M. Colleoni et al., Depression and degree of acceptance of adjuvant cytotoxic drugs, LANCET, 356(9238), 2000, pp. 1326-1327
Prediction of response to primary chemotherapy for operable breast cancer
Authors: Colleoni, M Orvieto, E Nole, F Orlando, L Minchella, I Viale, G Peruzzotti, G Robertson, C Noberasco, C Galimberti, V Sacchini, V Veronesi, P Zurrida, S Orecchia, R Goldhirsch, A
Citation: M. Colleoni et al., Prediction of response to primary chemotherapy for operable breast cancer, EUR J CANC, 35(4), 1999, pp. 574-579
Primary chemotherapy in operable breast cancer with favorable prognostic factors: A pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN)
Authors: Nole, F Minchella, I Colleoni, M Orvieto, E Munzone, E de Braud, F Peruzzotti, G Martinelli, G Zampino, MG Catania, C Pizzamiglio, M Veronesi, P Zurrida, S Galimberti, V Goldhirsch, A Veronesi, U
Citation: F. Nole et al., Primary chemotherapy in operable breast cancer with favorable prognostic factors: A pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN), ANN ONCOL, 10(8), 1999, pp. 993-996
Hepatic toxicity from cyclophosphamide, methotrexate, fluorouracil (cmf regimen)
Authors: Locatelli, M Colleoni, M Noberasco, C Nole, F Orlando, L Munzone, E Peruzzotti, G Goldhirsch, A
Citation: M. Locatelli et al., Hepatic toxicity from cyclophosphamide, methotrexate, fluorouracil (cmf regimen), ANN ONCOL, 10(11), 1999, pp. 1394-1395
Risultati: 1-8 |